Affirmative Family and Individual Psychotherapy for Sexual and Gender Minority Adults and Their Nonaccepting Parents
1 other identifier
interventional
124
2 countries
2
Brief Summary
The purpose of this study is to assess the efficacy of an LGBTQ-affirmative individual cognitive behavioral psychotherapy (CBT) and LGBTQ-affirmative family therapy (attachment-based family therapy for sexual and gender minority young adults; ABFT-SGM) delivered via telehealth to a sample of sexual and gender minority adults with nonaccepting parent(s) in New York, Pennsylvania, Connecticut, and Israel. The investigators will assess whether both treatments are associated with significant decreases in depressive and anxiety symptoms. The investigators will also assess whether and how each treatment achieves reductions in mental health symptoms through specific mechanisms (e.g., rejection sensitivity, internalized stigma, emotion dysregulation, parental rejection and acceptance).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Aug 2024
Typical duration for phase_3
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2023
CompletedFirst Posted
Study publicly available on registry
March 13, 2023
CompletedStudy Start
First participant enrolled
August 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
January 13, 2026
January 1, 2026
2.9 years
March 1, 2023
January 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in depression symptoms
Depressive symptoms will be measured using the 21-item Beck Depression Inventory-II (BDI). Items are rated on a scale from 0-3 where higher scores indicate greater depression symptoms, with a maximum score of 63.
Baseline, Immediate Post-intervention, 5-month Post-intervention
Change in anxiety symptoms
Anxiety symptoms will be measured using the 21-item Beck Anxiety Inventory (BAI). Items are rated on a scale from 0-3 where higher scores indicate greater anxiety symptoms, with a maximum score of 63.
Baseline, Immediate Post-intervention, 5-month Post-intervention
Secondary Outcomes (9)
Change in suicidal ideation
Baseline, Immediate Post-intervention, 5-month Post-intervention
Change in sexual orientation and gender modality concealment motivation, as relevant
Baseline, Immediate Post-intervention, 5-month Post-intervention
Change in sexual orientation and gender modality acceptance concerns, as relevant
Baseline, Immediate Post-intervention, 5-month Post-intervention
Change in explicit internalized stigma
Baseline, Immediate Post-intervention, 5-month Post-intervention
Change in emotion dysregulation
Baseline, Immediate Post-intervention, 5-month Post-intervention
- +4 more secondary outcomes
Study Arms (2)
LGBTQ-affirmative CBT
EXPERIMENTALIndividuals assigned to LGBTQ-affirmative cognitive behavioral therapy will receive 16 weekly individually-delivered sessions, directly after baseline assessment, delivered via telehealth. Based on the Unified Protocol, sessions will address minority stress mechanisms underlying sexual and gender minority mental health disparities.
ABFT-SGM
EXPERIMENTALIndividuals assigned to attachment-based family therapy for sexual and gender minorities will receive a 16-session sequence of family-based therapy delivered via telehealth. This sequence will include sessions with sexual and/or gender minority adult children alone, adult children and parent(s), and parent(s) alone. Sessions will address the quality parent-child relationship in relation to child sexual orientation and gender identity to target mental health disparities.
Interventions
16-session attachment-based family therapy for sexual and gender minority young adults and their nonaccepting parents
16-session LGBTQ-affirmative psychotherapy using cognitive behavioral techniques
Eligibility Criteria
You may qualify if:
- be 20 and older
- be fluent in English
- self-identify as lesbian, bisexual, queer, pansexual, or other non-heterosexual identity
- currently experience elevated depressive or anxiety symptoms (screened initially using a cutoff of ≥ 2.5 on the Brief Symptom Inventory-4 and further confirmed by the BDI and BAI).
- report at least moderate levels of parental rejection or low levels of parental acceptance, as measured using the PARSOS.
- have at least one rejecting/nonaccepting parent that agrees to participate in the therapy.
- live in New York State, Pennsylvania, Connecticut, or Israel.
You may not qualify if:
- report current mental health treatment ≥1 day/month (except for medication management ≤1 day/week)
- report beginning a new medication within the past 30 days
- exhibit active psychosis or active mania, as assessed by the SCID-Psych Screen.
- exhibit active suicidality or active homicidality, as assessed by the SIDAS
- be currently legally mandated to attend treatment
- demonstrate gross cognitive impairment, as assessed with the Telephone Interview for Cognitive Status
- do not have a parent willing to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- Ben-Gurion University of the Negevcollaborator
- Israel Science Foundationcollaborator
Study Sites (2)
Yale LGBTQ Mental Health Initiative with the Yale School of Public Health Office
New York, New York, 10001, United States
Ben-Gurion University Psychotherapy Research Lab
Beersheba, 84105, Israel
Related Publications (12)
Wang YP, Gorenstein C. Psychometric properties of the Beck Depression Inventory-II: a comprehensive review. Braz J Psychiatry. 2013 Oct-Dec;35(4):416-31. doi: 10.1590/1516-4446-2012-1048. Epub 2013 Dec 23.
PMID: 24402217BACKGROUNDBeck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. doi: 10.1037//0022-006x.56.6.893. No abstract available.
PMID: 3204199BACKGROUNDMohr JJ, Kendra MS. Revision and extension of a multidimensional measure of sexual minority identity: the Lesbian, Gay, and Bisexual Identity Scale. J Couns Psychol. 2011 Apr;58(2):234-245. doi: 10.1037/a0022858.
PMID: 21319899BACKGROUNDGouveia P, Ramos C, Brito J, Almeida TC, Cardoso J. The Difficulties in Emotion Regulation Scale - Short Form (DERS-SF): psychometric properties and invariance between genders. Psicol Reflex Crit. 2022 May 6;35(1):11. doi: 10.1186/s41155-022-00214-2.
PMID: 35522349BACKGROUNDKibrik EL, Cohen N, Stolowicz-Melman D, Levy A, Boruchovitz-Zamir R, Diamond GM. Measuring Adult Children's Perceptions of Their Parents' Acceptance and Rejection of Their Sexual Orientation: Initial Development of the Parental Acceptance and Rejection of Sexual Orientation Scale (PARSOS). J Homosex. 2019;66(11):1513-1534. doi: 10.1080/00918369.2018.1503460. Epub 2018 Aug 24.
PMID: 30142289BACKGROUNDKasch KL, Klein DN, Lara ME. A construct validation study of the Response Styles Questionnaire Rumination Scale in participants with a recent-onset major depressive episode. Psychol Assess. 2001 Sep;13(3):375-83. doi: 10.1037//1040-3590.13.3.375.
PMID: 11556274BACKGROUNDSteffens MC, Buchner A. Implicit Association Test: separating transsituationally stable and variable components of attitudes toward gay men. Exp Psychol. 2003;50(1):33-48. doi: 10.1027//1618-3169.50.1.33.
PMID: 12629959BACKGROUNDFraley RC, Heffernan ME, Vicary AM, Brumbaugh CC. The Experiences in Close Relationships-Relationship Structures questionnaire: a method for assessing attachment orientations across relationships. Psychol Assess. 2011 Sep;23(3):615-25. doi: 10.1037/a0022898.
PMID: 21443364BACKGROUNDTolin DF, Gilliam C, Wootton BM, Bowe W, Bragdon LB, Davis E, Hannan SE, Steinman SA, Worden B, Hallion LS. Psychometric Properties of a Structured Diagnostic Interview for DSM-5 Anxiety, Mood, and Obsessive-Compulsive and Related Disorders. Assessment. 2018 Jan;25(1):3-13. doi: 10.1177/1073191116638410. Epub 2016 Mar 17.
PMID: 26988404BACKGROUNDLang AJ, Norman SB, Means-Christensen A, Stein MB. Abbreviated brief symptom inventory for use as an anxiety and depression screening instrument in primary care. Depress Anxiety. 2009;26(6):537-43. doi: 10.1002/da.20471.
PMID: 19016462BACKGROUNDCook SE, Marsiske M, McCoy KJ. The use of the Modified Telephone Interview for Cognitive Status (TICS-M) in the detection of amnestic mild cognitive impairment. J Geriatr Psychiatry Neurol. 2009 Jun;22(2):103-9. doi: 10.1177/0891988708328214.
PMID: 19417219BACKGROUNDKroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
PMID: 11556941BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
John E Pachankis, PhD
Yale University
- PRINCIPAL INVESTIGATOR
Gary M Diamond, PhD
Ben-Gurion University of the Negev
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will be immediately assigned to either condition.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 1, 2023
First Posted
March 13, 2023
Study Start
August 13, 2024
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
January 13, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Data will be available 12 months after study completion for three years.
- Access Criteria
- Data access requests from qualified academic investigators for non-commercial research interests will be reviewed by study investigators. Requestors will be required to sign a data access agreement.
De-identified individual participant data will be made available to qualified researchers upon request to the PIs following study conclusion.